SYLMERA Trademark

Trademark Overview

On Friday, December 4, 2009, a trademark application was filed for SYLMERA with the United States Patent and Trademark Office. The USPTO has given the SYLMERA trademark a serial number of 77885957. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 7, 2013. This trademark is owned by JOHNSON & JOHNSON. The SYLMERA trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical preparations for the treatment of cancer
sylmera

General Information

Serial Number77885957
Word MarkSYLMERA
Filing DateFriday, December 4, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 7, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 13, 2010

Trademark Statements

Goods and ServicesHuman pharmaceutical preparations for the treatment of cancer
Translation of Words in MarkThe wording "SYLMERA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 11, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJOHNSON & JOHNSON
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001
Party NameJOHNSON & JOHNSON
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001

Trademark Events

Event DateEvent Description
Monday, October 7, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 7, 2013ABANDONMENT - NO USE STATEMENT FILED
Friday, February 22, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, February 21, 2013EXTENSION 5 GRANTED
Wednesday, February 20, 2013EXTENSION 5 FILED
Wednesday, February 20, 2013TEAS EXTENSION RECEIVED
Friday, August 31, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, August 30, 2012EXTENSION 4 GRANTED
Tuesday, August 28, 2012EXTENSION 4 FILED
Tuesday, August 28, 2012TEAS EXTENSION RECEIVED
Thursday, March 8, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, March 7, 2012EXTENSION 3 GRANTED
Tuesday, March 6, 2012EXTENSION 3 FILED
Tuesday, March 6, 2012TEAS EXTENSION RECEIVED
Friday, September 9, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, September 8, 2011EXTENSION 2 GRANTED
Wednesday, September 7, 2011EXTENSION 2 FILED
Thursday, September 8, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 7, 2011TEAS EXTENSION RECEIVED
Wednesday, March 9, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, March 7, 2011EXTENSION 1 GRANTED
Monday, March 7, 2011EXTENSION 1 FILED
Monday, March 7, 2011TEAS EXTENSION RECEIVED
Tuesday, September 7, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 13, 2010PUBLISHED FOR OPPOSITION
Wednesday, June 23, 2010NOTICE OF PUBLICATION
Thursday, June 10, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 8, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 26, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 26, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 25, 2010ASSIGNED TO LIE
Tuesday, May 4, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 10, 2010NON-FINAL ACTION MAILED
Tuesday, March 9, 2010NON-FINAL ACTION WRITTEN
Thursday, March 4, 2010ASSIGNED TO EXAMINER
Friday, December 11, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, December 8, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

sylmera cancer treatment preparations pharmaceutical human